Fighting Climate Change: Urban Greennes, Active Mobility and Health Co-benefits.

Respiratory and Allergic Symptoms Clinical Trial

— CLIMACTIONS  

Official title:

Fighting Climate Change: Urban Greennes, Active Mobility and Health Co-benefits.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04742179
• Other study ID #: 11/2020
• Status: Completed
• Phase: Phase 4
• Start date: January 11, 2022
• Est. completion date: May 11, 2022

Study information

• Verified date: December 2022
• Source: Istituto per la Ricerca e l'Innovazione Biomedica
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a prospective, non-randomized, controlled, interventional study aiming to assess, in a primary school in the city of Palermo, the health effects of a maintenance and care intervention of the school's green areas.

All children of the third, fourth and fifth classes of two school complexes of the same primary school will be selected. One complex will undergo maintenance and care of the green areas and gardens inside the school. The other complex will serve as a control group and will not undergo any intervention.

The study will involve three phases.

1. During the first phase (prior to the intervention) respiratory and allergic symptoms will be assessed through a standardized questionnaire to be administered to students, parents and teachers in both the school complexes.

2. During the second phase, the maintenance and care intervention plan will be implemented in the experimental complex.

3. During the third phase, 1 week after the maintenance intervention, respiratory and allergic symptoms will be re-assessed through a standardized questionnaire to be administered to the same students, parents and teachers in both the school complexes.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 175
• Est. completion date: May 11, 2022
• Est. primary completion date: May 11, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 7 Years to 11 Years

Eligibility

Inclusion Criteria:

• male or female gender

• age between 7 and 11 years

Exclusion Criteria:

• no exclusion criteria

Related Conditions & MeSH terms

• Respiratory and Allergic Symptoms

Intervention

Other:
• Manteinance and care intervention on the green areas.
Manteinance and care intervention on the green areas.

Locations

Country	Name	City	State
Italy	Institute of Translational Pharmacology	Palermo

Sponsors (1)

Lead Sponsor	Collaborator
Istituto per la Ricerca e l'Innovazione Biomedica

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Asthma symptoms at baseline	Presence of asthma symptoms before the maintenance intervention	Before the maintenance intervention
Primary	Rhinitis symptoms at baseline	Presence of rhinitis symptoms before the maintenance intervention	Before the maintenance intervention
Primary	Conjunctivitis symptoms at baseline	Presence of conjunctivitis symptoms before the maintenance intervention	Before the maintenance intervention
Primary	Asthma symptoms at follow-up	Presence of asthma symptoms after the maintenance intervention	7 days after the maintenance intervention
Primary	Rhinitis symptoms at follow-up	Presence of rhinitis symptoms after the maintenance intervention	7 days after the maintenance intervention
Primary	Conjunctivitis symptoms at follow-up	Presence of conjunctivitis symptoms after the maintenance intervention	7 days after the maintenance intervention